0.6901
2.11%
-0.0148
시장 영업 전:
.70
0.00995
+1.44%
Mink Therapeutics Inc (INKT) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
59.98%
0.0166
|
0.0415 | 0.1073 | 0.1464 | 0.1681 |
Operating Expenses
|
30.59%
3.8465
|
5.5416 | 5.3308 | 6.4897 | 6.0222 |
Benefits Costs and Expenses |
30.37%
3.8299
|
5.5001 | - | - | 5.8541 |
Costs And Expenses |
30.37%
3.8299
|
5.5001 | 5.3308 | 6.4897 | 5.8541 |
Provision For Loan, Lease, And Other Losses |
-
|
- | - | - | - |
Operating Income/Loss |
30.37%
-3.8299
|
-5.5001 | -5.2236 | -6.3433 | -5.8541 |
Net Interest Income/Expense |
59.98%
0.0166
|
0.0415 | 0.1073 | 0.1464 | 0.1681 |
Interest Income/Expense After Provision For Losses |
59.98%
0.0166
|
0.0415 | 0.1073 | 0.1464 | 0.1681 |
Income/Loss From Continuing Operations Before Tax |
30.14%
-3.8133
|
-5.4586 | 0.1073 | -6.197 | -5.686 |
Income/Loss From Continuing Operations After Tax |
30.14%
-3.8133
|
-5.4586 | -5.1163 | -6.197 | -5.686 |
Net Income/Loss
|
30.14%
-3.8133
|
-5.4586 | -5.1163 | -6.197 | -5.686 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
51,754%
34.64
|
0.0668 | 34.50 | 34.41 | 33.97 |
Diluted Average Shares |
51,754%
34.64
|
0.0668 | 34.50 | 34.41 | 33.97 |
Basic Earnings Per Share |
26.67%
-0.11
|
-0.15 | -0.15 | -0.18 | -0.17 |
Diluted Earnings Per Share |
26.67%
-0.11
|
-0.15 | -0.15 | -0.18 | -0.17 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):